Glucovance and interstitial lung disease Patient Reports February 12, 2012



Glucovance Side Effects Report #5069605-1
Glucovance side effect was reported by a Consumer or non-health professional from FRANCE on Aug 17, 2004. Female patient, 66 years of age, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with Glucovance. After drug was administered, patient experienced the following side effects: interstitial lung disease. Glucovance dosage: unknown. During the same period patient was treated with VOLTAREN, ZOCOR, CLORAZEPATE DIPOTASSIUM, FEMOSTON, GLUCOPHAGE. Patient was hospitalized. Patient recovered.

Glucovance Side Effects Report #4569022-4
Glucovance side effect was reported by a Consumer or non-health professional from on Aug 17, 2004. Female patient, 66 years of age, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with Glucovance. After drug was administered, patient experienced the following side effects: interstitial lung disease. Glucovance dosage: unknown. During the same period patient was treated with GLUCOPHAGE, VOLTAREN, ZOCOR, CLORAZEPATE DIPOTASSIUM, FEMOSTON. Patient was hospitalized. Patient recovered.

Glucovance Side Effects Report #4585370-6
Glucovance side effect was reported by a Consumer or non-health professional from on Aug 17, 2004. Female patient, 66 years of age, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with Glucovance. After drug was administered, patient experienced the following side effects: alveolitis, alveolitis allergic, central venous pressure increased, cryptogenic organizing pneumonia, feeling cold, glycosylated haemoglobin increased, interstitial lung disease, lung infiltration. Glucovance dosage: unknown. During the same period patient was treated with VOLTAREN, ZOCOR, CLORAZEPATE DIPOTASSIUM, FEMOSTON, GLUCOPHAGE. Patient was hospitalized. Patient recovered.

Glucovance Side Effects Report #4596643-5
Glucovance side effect was reported by a Consumer or non-health professional from on Aug 17, 2004. Female patient, 66 years of age, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with Glucovance. After drug was administered, patient experienced the following side effects: interstitial lung disease. Glucovance dosage: unknown. During the same period patient was treated with VOLTAREN, ZOCOR, CLORAZEPATE DIPOTASSIUM, FEMOSTON, GLUCOPHAGE. Patient was hospitalized. Patient recovered.


Glucovance Side Effects Report #4734868-6
Glucovance side effect was reported by a Consumer or non-health professional from FRANCE on Aug 17, 2004. Female patient, 66 years of age, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with Glucovance. After drug was administered, patient experienced the following side effects: interstitial lung disease. Glucovance dosage: unknown. During the same period patient was treated with VOLTAREN, ZOCOR, CLORAZEPATE DIPOTASSIUM, FEMOSTON, GLUCOPHAGE. Patient was hospitalized. Patient recovered.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Glucovance